MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
163 hedge funds and large institutions have $1.35B invested in Momenta Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 65 increasing their positions, 51 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
163
Holders Change
-3
Holders Change %
-1.81%
% of All Funds
3.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
65
Reduced
51
Closed
27
Calls
$2.78M
Puts
$602K
Net Calls
+$2.17M
Net Calls Change
+$1.01M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$34M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$18M |
| 3 |
TA
Teachers Advisors
New York
|
+$10.4M |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$9.08M |
| 5 |
VMI
VHCP Management II
New York
|
+$7.71M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$33.8M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$23.3M |
| 3 |
O
OrbiMed
New York
|
-$15.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$7.02M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.88M |
